The Effect of an Azygos Vein Coil on Defibrillation Threshold
1 other identifier
interventional
32
1 country
1
Brief Summary
When implantable cardiac defibrillators are implanted (ICDs), the defibrillation threshold (DFT), of the amount of energy required to effectively terminate life-threatening arrhythmias is determined. The device is then programmed to discharge a larger amount of energy in order to provide a safety margin. In some patients, the DFT is so high, that an adequate safety margin is not programmable. Placement of a defibrillation lead in the azygos vein has been found to be helpful in these patients. This goal of this trial is to attempt to quantify the average reduction in the DFT (if any) that results from the addition of the azygos lead.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Dec 2008
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2008
CompletedFirst Posted
Study publicly available on registry
November 26, 2008
CompletedStudy Start
First participant enrolled
December 15, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 18, 2009
CompletedResults Posted
Study results publicly available
September 28, 2018
CompletedSeptember 28, 2018
August 1, 2018
11 months
November 24, 2008
February 1, 2018
August 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in the DFT With an Azygos Vein Coil Versus the Standard SVC Coil.
Defibrillation threshold will be estimated by repeat defibrillation testing using an azygos coil and using an SVC coil (and compared). The outcome measure quoted below is the mean DFT using the azygos coil vs. the mean DFT using the standard configuration.
During the course of the implant procedure and testing
Study Arms (1)
Standard configuration vs. azygos coil
EXPERIMENTALThe DFT with the standard Superior Vena Cava (SVC) coil vs. DFT with the azygos coil. In this crossover study, each patient serves and own control, with defibrillation testing performed with and with the azygos coil
Interventions
Addition of an azygos vein defibrillation coil instead of a standard SVC coil.
Eligibility Criteria
You may not qualify if:
- Any contraindication to ICD or the inability to place an azygos vein coil.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Washington University School of Medicinelead
- Medtroniccollaborator
Study Sites (1)
Washington University
St Louis, Missouri, 63110, United States
Related Publications (2)
Cooper JA, Latacha MP, Soto GE, Garmany RG, Gleva MJ, Chen J, Faddis MN, Smith TW. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series. Pacing Clin Electrophysiol. 2008 Nov;31(11):1405-10. doi: 10.1111/j.1540-8159.2008.01203.x.
PMID: 18950297BACKGROUNDCesario D, Bhargava M, Valderrabano M, Fonarow GC, Wilkoff B, Shivkumar K. Azygos vein lead implantation: a novel adjunctive technique for implantable cardioverter defibrillator placement. J Cardiovasc Electrophysiol. 2004 Jul;15(7):780-3. doi: 10.1046/j.1540-8167.2004.03649.x.
PMID: 15250862BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Timothy W. Smith
- Organization
- Washington University in St. Louis
Study Officials
- PRINCIPAL INVESTIGATOR
Timothy W. Smith, DPhil, MD
Washington University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2008
First Posted
November 26, 2008
Study Start
December 15, 2008
Primary Completion
November 18, 2009
Study Completion
November 18, 2009
Last Updated
September 28, 2018
Results First Posted
September 28, 2018
Record last verified: 2018-08